[Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer]
- PMID: 22218503
- DOI: 10.1007/s00066-011-0033-8
[Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer]
Comment on
-
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.J Clin Oncol. 2011 May 20;29(15):2020-6. doi: 10.1200/JCO.2010.31.4377. Epub 2011 Apr 4. J Clin Oncol. 2011. PMID: 21464418 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
